[Successful treatment of MPO-ANCA associated glomerulonephritis with high dose intravenous immunoglobulin].
Namba
Tomoko
T
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Osaka.
Mikami
Satoshi
S
Yamato
Masahumi
M
Nagatoya
Katsuyuki
K
Iwatani
Hirotsugu
H
Nagasawa
Yasuyuki
Y
Ito
Takahito
T
Imai
Enyu
E
D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D009195:Peroxidase / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage; D016896:Treatment Outcome
D019268:Antibodies, Antineutrophil Cytoplasmic; D015415:Biomarkers; D016756:Immunoglobulins, Intravenous; D011239:Prednisolone; D009195:Peroxidase